Related Experiment Video
Updated: Apr 28, 2026

Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids
Published on: October 13, 2021
Core-shell structure microcapsules with dual pH-responsive drug release function.
Chih-Hui Yang1, Chih-Yu Wang, Alexandru Mihai Grumezescu
1Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan.
We developed dual pH-responsive core-shell microcapsules using electrostatic and microfluidic droplet techniques for controlled drug delivery. These biocompatible microcapsules show enhanced drug release efficiency in acidic and alkaline conditions.
Area of Science:
- Materials Science
- Biotechnology
- Drug Delivery Systems
Background:
- Developing microcapsules with controlled release properties is crucial for effective drug delivery.
- pH-responsive materials offer targeted drug release in specific physiological environments.
- Combining different materials can create synergistic effects for enhanced functionality.
Purpose of the Study:
- To fabricate dual pH-responsive core-shell microcapsules using combined electrostatic droplet (ESD) and microfluidic droplet (MFD) techniques.
- To evaluate the drug release efficiency and biocompatibility of the synthesized microcapsules.
- To investigate the potential of these microcapsules as dual-drug carriers.
Main Methods:
- Core-shell microcapsules were synthesized using a combination of ESD and MFD techniques.
- Alginate was used for the core and chitosan for the shell, creating a monodisperse structure.
- Two model drugs, ampicillin (shell) and diclofenac (core), were loaded for drug delivery studies.
- Biocompatibility was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Main Results:
- Monodisperse core-shell microcapsules with controllable size were successfully fabricated.
- The microcapsules demonstrated dual pH-responsive release in both acidic and alkaline environments.
- Core-shell structures exhibited superior drug release efficiency compared to individual core or shell particles.
- The MTT assay confirmed positive cell viability (above 80%), indicating good biocompatibility.
Conclusions:
- The synthesized core-shell microcapsules are effective dual pH-responsive drug carriers.
- The combined ESD and MFD approach offers a versatile method for producing functional microcapsules.
- These microcapsules show significant potential for targeted and efficient dual-drug delivery applications.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Overview
Modified-Release Drug Delivery Systems: Site-Targeted

